KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Treasury Shares (2020 - 2025)

Historic Treasury Shares for Supernus Pharmaceuticals (SUPN) over the last 6 years, with Q3 2025 value amounting to $397543.0.

  • Supernus Pharmaceuticals' Treasury Shares fell 142.75% to $397543.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $397543.0, marking a year-over-year decrease of 142.75%. This contributed to the annual value of $378165.0 for FY2024, which is 2599.58% up from last year.
  • Supernus Pharmaceuticals' Treasury Shares amounted to $397543.0 in Q3 2025, which was down 142.75% from $439216.0 recorded in Q2 2025.
  • Supernus Pharmaceuticals' 5-year Treasury Shares high stood at $439216.0 for Q2 2025, and its period low was $89125.0 during Q3 2021.
  • Its 5-year average for Treasury Shares is $279131.6, with a median of $306516.0 in 2023.
  • In the last 5 years, Supernus Pharmaceuticals' Treasury Shares soared by 24206.49% in 2021 and then tumbled by 142.75% in 2025.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Treasury Shares stood at $89125.0 in 2021, then soared by 126.37% to $201750.0 in 2022, then soared by 48.77% to $300141.0 in 2023, then grew by 26.0% to $378165.0 in 2024, then rose by 5.12% to $397543.0 in 2025.
  • Its Treasury Shares was $397543.0 in Q3 2025, compared to $439216.0 in Q2 2025 and $407867.0 in Q1 2025.